MEDIGARD LIMITED - Announcements

0.00%

2.0¢

Currently unlisted.

Medigard Limited is engaged in the development of medical instruments in Australia. The... Medigard Limited is engaged in the development of medical instruments in Australia. The principal activities of the Company are liaising with Shanghai Sol-Millennium Medical Products Co., Ltd for the improvement of the Blood Collection Device; bundling of the Blood Collection Device with its Flash Back Needle, and the progressing and maintenance of patents. It designs and manufactures a range of products, including Auto-retractable Syringe and Manual Retractable Syringe. The Company offers its products for healthcare workers and their patients. Its Blood Collection Device features vacuum technology to capture the needle after blood has been collected. Its Flash Back Needle allows healthcare workers immediate visual confirmation of a venipuncture. The Company's Intravenous Valve operates as a component of the cannula and a standalone device, which is used as access points in the catheters in preference to a syringe for delivering fluid, administering drugs and taking blood samples.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

MGZ	Suspension from Official Quotation	PRICE SENSITIVE	22/02/21	429.23KB	Share
MGZ	Letter to Shareholders	PRICE SENSITIVE	12/11/20	243.75KB	Share
MGZ	Preliminary Final Report	PRICE SENSITIVE	31/08/20	478.58KB	Share
MGZ	Proposed issue of shares, Project and Funding Update	PRICE SENSITIVE	30/04/20	106.29KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/20	248.82KB	Share
MGZ	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/20	988.8KB	Share
MGZ	Response to ASX Appendix 4C Query	PRICE SENSITIVE	10/02/20	367KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	03/02/20	182.54KB	Share
MGZ	Response to ASX Appendix 4C Query	PRICE SENSITIVE	29/10/19	368.92KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	23/10/19	194.33KB	Share
MGZ	Preliminary Final Report	PRICE SENSITIVE	29/08/19	198.18KB	Share
MGZ	Settlement of convertible notes, balance sheet restoration	PRICE SENSITIVE	28/08/19	65.46KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/19	196.61KB	Share
MGZ	Update on suspension	PRICE SENSITIVE	30/04/19	141.47KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/19	196.92KB	Share
MGZ	Suspension from Official Quotation	PRICE SENSITIVE	08/03/19	215.07KB	Share
MGZ	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/19	973.27KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/19	204.64KB	Share
MGZ	Medigard KT009 project and funding strategy	PRICE SENSITIVE	11/12/18	216.74KB	Share
MGZ	Explaining Medigard's New KT009 Program	PRICE SENSITIVE	14/11/18	338.06KB	Share
MGZ	License Agreement with Kunovus Pty Ltd	PRICE SENSITIVE	08/11/18	201.1KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/18	311.19KB	Share
MGZ	Technology License and Clinial Development Program Agreement	PRICE SENSITIVE	30/10/18	356.62KB	Share
MGZ	Letter to Shareholders	PRICE SENSITIVE	04/10/18	117.78KB	Share
MGZ	Preliminary Final Report	PRICE SENSITIVE	30/08/18	386.1KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	24/07/18	314.31KB	Share
MGZ	Announcement re Technology and Commercialisation Agreement	PRICE SENSITIVE	29/05/18	359.07KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	27/04/18	314.14KB	Share
MGZ	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/18	386.74KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/18	307.12KB	Share
MGZ	Share Purchase Plan Offer Documents	PRICE SENSITIVE	08/12/17	826.46KB	Share
MGZ	Share Purchase Plan	PRICE SENSITIVE	07/12/17	293.5KB	Share
MGZ	Private Placement Commitments	PRICE SENSITIVE	31/10/17	342.85KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/17	306.69KB	Share
MGZ	Preliminary Final Report	PRICE SENSITIVE	31/08/17	387.3KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/17	228.84KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	24/04/17	227.79KB	Share
MGZ	Half Year Accounts	PRICE SENSITIVE	28/02/17	508.62KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/17	227.37KB	Share
MGZ	Appendix 4C - quarterly-MGZ.AX	PRICE SENSITIVE	24/10/16	227.42KB	Share
MGZ	Preliminary Final Report-MGZ.AX	PRICE SENSITIVE	28/08/16	384.05KB	Share
MGZ	Preliminary Final Report-MGZ.AX	PRICE SENSITIVE	25/08/16	384.05KB	Share
MGZ	Appendix 4C - quarterly-MGZ.AX	PRICE SENSITIVE	29/07/16	170.24KB	Share
MGZ	Appendix 4C - quarterly-MGZ.AX	PRICE SENSITIVE	27/04/16	170.18KB	Share
MGZ	Half Year Report and Accounts	PRICE SENSITIVE	26/02/16	477.72KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/16	171.25KB	Share
MGZ	Response to ASX Appendix 4C Query	PRICE SENSITIVE	05/11/15	361.5KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	27/10/15	169.57KB	Share
MGZ	Preliminary Final Report	PRICE SENSITIVE	31/08/15	378.69KB	Share
MGZ	Shareholder Update	PRICE SENSITIVE	21/07/15	126.8KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	21/07/15	169.66KB	Share
MGZ	Shareholder Update	PRICE SENSITIVE	14/05/15	193.51KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/15	169.13KB	Share
MGZ	Half Year Accounts	PRICE SENSITIVE	26/02/15	448.07KB	Share
MGZ	Response to ASX Price Query	PRICE SENSITIVE	06/02/15	108.42KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	21/01/15	169.24KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	24/10/14	168.57KB	Share
MGZ	Preliminary Final Report	PRICE SENSITIVE	29/08/14	117.8KB	Share
MGZ	Convertible Note Deed	PRICE SENSITIVE	31/07/14	166.72KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/14	169.72KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/14	169.16KB	Share
MGZ	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/14	223.63KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/14	169.55KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	21/10/13	169.31KB	Share
MGZ	Preliminary Final Report	PRICE SENSITIVE	28/08/13	368.26KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	04/07/13	170.21KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	18/04/13	33.51KB	Share
MGZ	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/13	449.21KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	10/01/13	120.92KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/12	120.4KB	Share
MGZ	Medigard announces Heads of Agreement	PRICE SENSITIVE	24/10/12	85.04KB	Share
MGZ	Preliminary Final Report	PRICE SENSITIVE	28/08/12	126.09KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/12	35.28KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/12	35.5KB	Share
MGZ	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/12	207.71KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/12	35.56KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	25/10/11	28.55KB	Share
MGZ	Preliminary Final Report	PRICE SENSITIVE	31/08/11	127.02KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/11	37.11KB	Share
MGZ	Appendix 4C - 31 March 2011	PRICE SENSITIVE	29/04/11	40.25KB	Share
MGZ	Notice of Resignation CEO and Company Secretary	PRICE SENSITIVE	24/02/11	7.66KB	Share
MGZ	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/11	1.27MB	Share
MGZ	Grant of Japanese Patent (BCD) and IPRP (1mL Syringe)	PRICE SENSITIVE	01/02/11	10.15KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/11	44.31KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	28/10/10	59.89KB	Share
MGZ	Grant of Patent in South Africa	PRICE SENSITIVE	21/09/10	7.98KB	Share
MGZ	Preliminary Final Report	PRICE SENSITIVE	31/08/10	123.91KB	Share
MGZ	Market Announcement	PRICE SENSITIVE	05/08/10	33.88KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/10	38.98KB	Share
MGZ	Prospectus	PRICE SENSITIVE	27/07/10	1.36MB	Share
MGZ	Renounceable Issue	PRICE SENSITIVE	27/07/10	306.39KB	Share
MGZ	Signing of US Manufacturing and Distribution Agreements	PRICE SENSITIVE	26/05/10	175.9KB	Share
MGZ	Trading Halt	PRICE SENSITIVE	25/05/10	60.67KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	16/04/10	36.39KB	Share
MGZ	Clinical Trial Results USA - Medigard Syringe	PRICE SENSITIVE	06/04/10	9.66KB	Share
MGZ	Marketing and Product Evaluation USA	PRICE SENSITIVE	24/03/10	13.96KB	Share
MGZ	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/10	256.67KB	Share
MGZ	Appendix 4C - quarterly	PRICE SENSITIVE	25/01/10	43KB	Share
MGZ	Medigard Signs US Manufacturer	PRICE SENSITIVE	11/12/09	61.22KB	Share
MGZ	Marketing - Product Evaluation USA	PRICE SENSITIVE	12/11/09	22.03KB	Share

MGZ Suspension from Official Quotation
22/02/21	PRICE SENSITIVE	429.23KB	Share
MGZ Letter to Shareholders
12/11/20	PRICE SENSITIVE	243.75KB	Share
MGZ Preliminary Final Report
31/08/20	PRICE SENSITIVE	478.58KB	Share
MGZ Proposed issue of shares, Project and Funding Update
30/04/20	PRICE SENSITIVE	106.29KB	Share
MGZ Appendix 4C - quarterly
30/04/20	PRICE SENSITIVE	248.82KB	Share
MGZ Half Yearly Report and Accounts
28/02/20	PRICE SENSITIVE	988.8KB	Share
MGZ Response to ASX Appendix 4C Query
10/02/20	PRICE SENSITIVE	367KB	Share
MGZ Appendix 4C - quarterly
03/02/20	PRICE SENSITIVE	182.54KB	Share
MGZ Response to ASX Appendix 4C Query
29/10/19	PRICE SENSITIVE	368.92KB	Share
MGZ Appendix 4C - quarterly
23/10/19	PRICE SENSITIVE	194.33KB	Share
MGZ Preliminary Final Report
29/08/19	PRICE SENSITIVE	198.18KB	Share
MGZ Settlement of convertible notes, balance sheet restoration
28/08/19	PRICE SENSITIVE	65.46KB	Share
MGZ Appendix 4C - quarterly
29/07/19	PRICE SENSITIVE	196.61KB	Share
MGZ Update on suspension
30/04/19	PRICE SENSITIVE	141.47KB	Share
MGZ Appendix 4C - quarterly
30/04/19	PRICE SENSITIVE	196.92KB	Share
MGZ Suspension from Official Quotation
08/03/19	PRICE SENSITIVE	215.07KB	Share
MGZ Half Yearly Report and Accounts
27/02/19	PRICE SENSITIVE	973.27KB	Share
MGZ Appendix 4C - quarterly
31/01/19	PRICE SENSITIVE	204.64KB	Share
MGZ Medigard KT009 project and funding strategy
11/12/18	PRICE SENSITIVE	216.74KB	Share
MGZ Explaining Medigard's New KT009 Program
14/11/18	PRICE SENSITIVE	338.06KB	Share
MGZ License Agreement with Kunovus Pty Ltd
08/11/18	PRICE SENSITIVE	201.1KB	Share
MGZ Appendix 4C - quarterly
31/10/18	PRICE SENSITIVE	311.19KB	Share
MGZ Technology License and Clinial Development Program Agreement
30/10/18	PRICE SENSITIVE	356.62KB	Share
MGZ Letter to Shareholders
04/10/18	PRICE SENSITIVE	117.78KB	Share
MGZ Preliminary Final Report
30/08/18	PRICE SENSITIVE	386.1KB	Share
MGZ Appendix 4C - quarterly
24/07/18	PRICE SENSITIVE	314.31KB	Share
MGZ Announcement re Technology and Commercialisation Agreement
29/05/18	PRICE SENSITIVE	359.07KB	Share
MGZ Appendix 4C - quarterly
27/04/18	PRICE SENSITIVE	314.14KB	Share
MGZ Half Yearly Report and Accounts
28/02/18	PRICE SENSITIVE	386.74KB	Share
MGZ Appendix 4C - quarterly
30/01/18	PRICE SENSITIVE	307.12KB	Share
MGZ Share Purchase Plan Offer Documents
08/12/17	PRICE SENSITIVE	826.46KB	Share
MGZ Share Purchase Plan
07/12/17	PRICE SENSITIVE	293.5KB	Share
MGZ Private Placement Commitments
31/10/17	PRICE SENSITIVE	342.85KB	Share
MGZ Appendix 4C - quarterly
31/10/17	PRICE SENSITIVE	306.69KB	Share
MGZ Preliminary Final Report
31/08/17	PRICE SENSITIVE	387.3KB	Share
MGZ Appendix 4C - quarterly
31/07/17	PRICE SENSITIVE	228.84KB	Share
MGZ Appendix 4C - quarterly
24/04/17	PRICE SENSITIVE	227.79KB	Share
MGZ Half Year Accounts
28/02/17	PRICE SENSITIVE	508.62KB	Share
MGZ Appendix 4C - quarterly
30/01/17	PRICE SENSITIVE	227.37KB	Share
MGZ Appendix 4C - quarterly-MGZ.AX
24/10/16	PRICE SENSITIVE	227.42KB	Share
MGZ Preliminary Final Report-MGZ.AX
28/08/16	PRICE SENSITIVE	384.05KB	Share
MGZ Preliminary Final Report-MGZ.AX
25/08/16	PRICE SENSITIVE	384.05KB	Share
MGZ Appendix 4C - quarterly-MGZ.AX
29/07/16	PRICE SENSITIVE	170.24KB	Share
MGZ Appendix 4C - quarterly-MGZ.AX
27/04/16	PRICE SENSITIVE	170.18KB	Share
MGZ Half Year Report and Accounts
26/02/16	PRICE SENSITIVE	477.72KB	Share
MGZ Appendix 4C - quarterly
29/01/16	PRICE SENSITIVE	171.25KB	Share
MGZ Response to ASX Appendix 4C Query
05/11/15	PRICE SENSITIVE	361.5KB	Share
MGZ Appendix 4C - quarterly
27/10/15	PRICE SENSITIVE	169.57KB	Share
MGZ Preliminary Final Report
31/08/15	PRICE SENSITIVE	378.69KB	Share
MGZ Shareholder Update
21/07/15	PRICE SENSITIVE	126.8KB	Share
MGZ Appendix 4C - quarterly
21/07/15	PRICE SENSITIVE	169.66KB	Share
MGZ Shareholder Update
14/05/15	PRICE SENSITIVE	193.51KB	Share
MGZ Appendix 4C - quarterly
30/04/15	PRICE SENSITIVE	169.13KB	Share
MGZ Half Year Accounts
26/02/15	PRICE SENSITIVE	448.07KB	Share
MGZ Response to ASX Price Query
06/02/15	PRICE SENSITIVE	108.42KB	Share
MGZ Appendix 4C - quarterly
21/01/15	PRICE SENSITIVE	169.24KB	Share
MGZ Appendix 4C - quarterly
24/10/14	PRICE SENSITIVE	168.57KB	Share
MGZ Preliminary Final Report
29/08/14	PRICE SENSITIVE	117.8KB	Share
MGZ Convertible Note Deed
31/07/14	PRICE SENSITIVE	166.72KB	Share
MGZ Appendix 4C - quarterly
30/07/14	PRICE SENSITIVE	169.72KB	Share
MGZAppendix 4C - quarterly
30/04/14	PRICE SENSITIVE	169.16KB	Share
MGZHalf Yearly Report and Accounts
28/02/14	PRICE SENSITIVE	223.63KB	Share
MGZAppendix 4C - quarterly
30/01/14	PRICE SENSITIVE	169.55KB	Share
MGZAppendix 4C - quarterly
21/10/13	PRICE SENSITIVE	169.31KB	Share
MGZPreliminary Final Report
28/08/13	PRICE SENSITIVE	368.26KB	Share
MGZAppendix 4C - quarterly
04/07/13	PRICE SENSITIVE	170.21KB	Share
MGZAppendix 4C - quarterly
18/04/13	PRICE SENSITIVE	33.51KB	Share
MGZHalf Yearly Report and Accounts
28/02/13	PRICE SENSITIVE	449.21KB	Share
MGZAppendix 4C - quarterly
10/01/13	PRICE SENSITIVE	120.92KB	Share
MGZAppendix 4C - quarterly
29/10/12	PRICE SENSITIVE	120.4KB	Share
MGZMedigard announces Heads of Agreement
24/10/12	PRICE SENSITIVE	85.04KB	Share
MGZPreliminary Final Report
28/08/12	PRICE SENSITIVE	126.09KB	Share
MGZAppendix 4C - quarterly
30/07/12	PRICE SENSITIVE	35.28KB	Share
MGZAppendix 4C - quarterly
30/04/12	PRICE SENSITIVE	35.5KB	Share
MGZHalf Yearly Report and Accounts
29/02/12	PRICE SENSITIVE	207.71KB	Share
MGZAppendix 4C - quarterly
30/01/12	PRICE SENSITIVE	35.56KB	Share
MGZAppendix 4C - quarterly
25/10/11	PRICE SENSITIVE	28.55KB	Share
MGZPreliminary Final Report
31/08/11	PRICE SENSITIVE	127.02KB	Share
MGZAppendix 4C - quarterly
29/07/11	PRICE SENSITIVE	37.11KB	Share
MGZAppendix 4C - 31 March 2011
29/04/11	PRICE SENSITIVE	40.25KB	Share
MGZNotice of Resignation CEO and Company Secretary
24/02/11	PRICE SENSITIVE	7.66KB	Share
MGZHalf Yearly Report and Accounts
24/02/11	PRICE SENSITIVE	1.27MB	Share
MGZGrant of Japanese Patent (BCD) and IPRP (1mL Syringe)
01/02/11	PRICE SENSITIVE	10.15KB	Share
MGZAppendix 4C - quarterly
28/01/11	PRICE SENSITIVE	44.31KB	Share
MGZAppendix 4C - quarterly
28/10/10	PRICE SENSITIVE	59.89KB	Share
MGZGrant of Patent in South Africa
21/09/10	PRICE SENSITIVE	7.98KB	Share
MGZPreliminary Final Report
31/08/10	PRICE SENSITIVE	123.91KB	Share
MGZMarket Announcement
05/08/10	PRICE SENSITIVE	33.88KB	Share
MGZAppendix 4C - quarterly
29/07/10	PRICE SENSITIVE	38.98KB	Share
MGZProspectus
27/07/10	PRICE SENSITIVE	1.36MB	Share
MGZRenounceable Issue
27/07/10	PRICE SENSITIVE	306.39KB	Share
MGZSigning of US Manufacturing and Distribution Agreements
26/05/10	PRICE SENSITIVE	175.9KB	Share
MGZTrading Halt
25/05/10	PRICE SENSITIVE	60.67KB	Share
MGZAppendix 4C - quarterly
16/04/10	PRICE SENSITIVE	36.39KB	Share
MGZClinical Trial Results USA - Medigard Syringe
06/04/10	PRICE SENSITIVE	9.66KB	Share
MGZMarketing and Product Evaluation USA
24/03/10	PRICE SENSITIVE	13.96KB	Share
MGZHalf Yearly Report and Accounts
26/02/10	PRICE SENSITIVE	256.67KB	Share
MGZAppendix 4C - quarterly
25/01/10	PRICE SENSITIVE	43KB	Share
MGZMedigard Signs US Manufacturer
11/12/09	PRICE SENSITIVE	61.22KB	Share
MGZMarketing - Product Evaluation USA
12/11/09	PRICE SENSITIVE	22.03KB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

MEDIGARD LIMITED - Announcements

Corporate Spotlight
Not Yet Available

Announcements

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

MEDIGARD LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

Corporate Spotlight
Not Yet Available